Vir Biotechnology Inc (VIR)
6.95
+0.21
(+3.12%)
USD |
NASDAQ |
Nov 21, 16:00
6.965
+0.02
(+0.22%)
After-Hours: 20:00
Vir Biotechnology Price: 6.95 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 6.74 | 6.995 | 6.56 | 6.95 | 1.848M |
| Nov 20, 2024 | 6.86 | 7.025 | 6.62 | 6.74 | 1.474M |
| Nov 19, 2024 | 7.09 | 7.37 | 6.86 | 6.93 | 2.295M |
| Nov 18, 2024 | 8.01 | 8.02 | 7.00 | 7.03 | 2.251M |
| Nov 15, 2024 | 8.70 | 8.71 | 7.86 | 8.01 | 1.481M |
| Nov 14, 2024 | 8.92 | 9.095 | 8.63 | 8.64 | 766274.0 |
| Nov 13, 2024 | 9.35 | 9.43 | 8.96 | 8.98 | 697166.0 |
| Nov 12, 2024 | 9.75 | 9.75 | 9.155 | 9.25 | 1.088M |
| Nov 11, 2024 | 9.73 | 10.12 | 9.61 | 9.87 | 817386.0 |
| Nov 08, 2024 | 9.70 | 9.81 | 9.48 | 9.60 | 940693.0 |
| Nov 07, 2024 | 10.04 | 10.30 | 9.75 | 9.77 | 902277.0 |
| Nov 06, 2024 | 9.80 | 10.44 | 9.52 | 10.17 | 2.141M |
| Nov 05, 2024 | 9.33 | 9.65 | 9.20 | 9.64 | 1.112M |
| Nov 04, 2024 | 9.26 | 9.505 | 9.025 | 9.37 | 1.548M |
| Nov 01, 2024 | 7.14 | 9.74 | 7.12 | 9.26 | 7.289M |
| Oct 31, 2024 | 7.65 | 7.66 | 7.45 | 7.49 | 1.274M |
| Oct 30, 2024 | 7.55 | 7.82 | 7.53 | 7.60 | 802362.0 |
| Oct 29, 2024 | 7.75 | 7.78 | 7.56 | 7.61 | 782124.0 |
| Oct 28, 2024 | 7.57 | 7.92 | 7.50 | 7.75 | 1.904M |
| Oct 25, 2024 | 7.36 | 7.755 | 7.36 | 7.48 | 1.111M |
| Oct 24, 2024 | 7.52 | 7.525 | 7.24 | 7.35 | 732614.0 |
| Oct 23, 2024 | 7.59 | 7.68 | 7.495 | 7.52 | 851541.0 |
| Oct 22, 2024 | 7.62 | 7.69 | 7.478 | 7.61 | 623284.0 |
| Oct 21, 2024 | 7.62 | 7.76 | 7.57 | 7.65 | 747332.0 |
| Oct 18, 2024 | 7.75 | 7.80 | 7.560 | 7.63 | 451390.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.74
Minimum
Nov 20 2024
83.07
Maximum
Jan 27 2021
26.66
Average
25.63
Median
Price Benchmarks
| Pfizer Inc | 25.13 |
| Biomarin Pharmaceutical Inc | 63.45 |
| Arbutus Biopharma Corp | 3.46 |
| GlycoMimetics Inc | 0.32 |
| FibroGen Inc | 0.3872 |
Price Related Metrics
| PS Ratio | 15.24 |
| Price to Book Value | 0.7731 |
| Earnings Yield | -56.28% |
| Market Cap | 959.22M |